BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Mirum Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 4:14 pm Sale | 2025-09-30 | 13G | Mirum Pharmaceuticals, Inc. MIRM | BIOTECHNOLOGY VALUE FUND L P | 1,495,290 3.000% | -1,580,617 (-51.39%) | Filing |
| 2024-11-14 4:37 pm Sale | 2024-09-30 | 13G | Mirum Pharmaceuticals, Inc. MIRM | BIOTECHNOLOGY VALUE FUND L P | 3,075,907 6.400% | -1,294,117 (-29.61%) | Filing |
| 2023-09-18 4:35 pm Purchase | 2023-09-07 | 13G | Mirum Pharmaceuticals, Inc. MIRM | BIOTECHNOLOGY VALUE FUND L P | 4,370,024 9.400% | 4,370,024 (New Position) | Filing |